FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New ...
A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose. In studies in mice, the researchers showed that an mRNA influenza ...
In recent years, messenger RNA (mRNA) vaccines have shown significant success in preventing viral and bacterial infections, ...
Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...
Accelerated by the COVID-19 pandemic, research is now exploring vaccines capable not only of preventing infections, but also ...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...
A research team from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Tsinghua University has developed a new mRNA vaccine delivery method that could improve ...
Pfizer’s mRNA flu shot prevented more flu-like illness than a standard vaccine More than 18,000 adults took part in the study Side effects were mild and went away quickly FRIDAY, Nov. 21, 2025 ...